Maintenance of Siemens Inveon scanners beyond 2022
|
|
6
|
1036
|
May 6, 2022
|
Characterization of a metastatic patient derived model of adenocarcinoma pancreas (20 subjects)
|
|
0
|
387
|
January 17, 2021
|
Legislation and Regulation around Nuclear Medicine
|
|
1
|
683
|
November 5, 2021
|
LIFEx (Image Analysis)
|
|
0
|
711
|
June 14, 2021
|
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma data collection (65 subjects)
|
|
0
|
222
|
January 17, 2021
|
The Cancer Genome Atlas Thyroid Cancer data collection (6 subjects)
|
|
0
|
247
|
January 17, 2021
|
The Cancer Genome Atlas Prostate Adenocarcinoma data collection (14 subjects)
|
|
0
|
268
|
January 17, 2021
|
The Cancer Genome Atlas Lung Squamous Cell Carcinoma data collection (37 subjects)
|
|
0
|
246
|
January 16, 2021
|
The Cancer Genome Atlas Lung Adenocarcinoma data collection (69 subjects)
|
|
0
|
222
|
January 16, 2021
|
The Cancer Genome Atlas Liver Hepatocellular Carcinoma data collection (97 subjects)
|
|
0
|
256
|
January 16, 2021
|
The Cancer Genome Atlas Cervical Kidney renal papillary cell carcinoma data collection (33 subjects)
|
|
0
|
236
|
January 16, 2021
|
The Cancer Genome Atlas Head-Neck Squamous Cell Carcinoma data collection (227 subjects)
|
|
0
|
221
|
January 16, 2021
|
The Cancer Genome Atlas Urothelial Bladder Carcinoma data collection (120 subjects)
|
|
0
|
219
|
January 16, 2021
|
Soft tissue sarcoma (51 subjects)
|
|
0
|
227
|
January 9, 2021
|
RIDER : Phantom PET/CT (20 subjects)
|
|
0
|
304
|
January 9, 2021
|
RIDER : Lung PET/CT (244 subjects)
|
|
0
|
345
|
January 9, 2021
|
Quantitative Imaging Network : Head and Neck (279 subjects)
|
|
0
|
279
|
January 5, 2021
|
Quantitative Imaging Network : Breast (67 subjects)
|
|
0
|
289
|
January 5, 2021
|
Quantitative Imaging Network : PET phantom (2 subjects)
|
|
0
|
234
|
January 4, 2021
|
Non-Small Cell Lung Cancer : Radiogenomics (211 subjects)
|
|
0
|
243
|
December 30, 2020
|
NaF Prostate (9 subjects)
|
|
0
|
233
|
December 30, 2020
|
Large-Scale CT and PET/CT Dataset for Lung Cancer Diagnosis (363 subjects)
|
|
0
|
912
|
December 27, 2020
|
Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma (242 subjects)
|
|
0
|
249
|
December 10, 2020
|
Head and Neck Cetuximab (111 subjects)
|
|
0
|
238
|
December 20, 2020
|
Head and Neck PET-CT (298 subjects)
|
|
0
|
299
|
December 20, 2020
|
Clinical Proteomic Tumor Analysis Consortium Uterine Corpus Endometrial Carcinoma cohort (250 subjects)
|
|
0
|
239
|
December 11, 2020
|
Clinical Proteomic Tumor Analysis Consortium Sarcomas cohort (94 subjects)
|
|
0
|
257
|
December 11, 2020
|
Clinical Proteomic Tumor Analysis Consortium Pancreatic Ductal Adenocarcinoma cohort (168 subjects)
|
|
0
|
242
|
December 11, 2020
|
Clinical Proteomic Tumor Analysis Consortium Lung Adenocarcinoma cohort (244 subjects)
|
|
0
|
255
|
December 11, 2020
|
Clinical Proteomic Tumor Analysis Consortium Lung Squamous Cell Carcinoma cohort (212 subjects)
|
|
0
|
256
|
December 11, 2020
|